Mandate

Vinge advises Adelis in connection with the acquisition of Logent

November 12, 2013

Vinge is advising Adelis Equity Partners Fund 1 AB in connection with its acquisition of Logent AB (“Logent”) from the company’s two founders and Inter IKEA Investments AB. The acquisition is taking place together with the company’s management. It is anticipated that the transaction will be completed by the end of November 2013. Logent was founded in 2006 and has had growth in sales over the last five years of more than 60% per year, both organically and as a result of strategic acquisitions. Logent currently has an extensive network of on-site solutions in Sweden and Norway and has approximately 3500 employees. Logent’s turnover for 2013 is expected to amount to approximately SEK 1.3 billion.

Vinge’s team consists of responsible partner Christina Kokko together with Johan Mattsson and Gustav Jönsson. Partner Mikael Ståhl and associates Sofia Graflund and Emelie Klefbeck advised on acquisition financing issues. Partners Mattias Scömer, Odile Fallenius and Johan Larsson and associates Ulf Nilsson and Emelie Parland advised Adelis in relation to funds, tax, and VAT issues.

Related

Vinge advises Spetses Investments and Bacara Holdings on the public offer for IRRAS

A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
October 03, 2023

Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023